For example, in cancer cell line models of NSCLC, transcription factor Six2′s overexpression caused promoter methylation of CDH1, inhibiting E-cadherin expression and enhancing stemness and chemosensitivity [88]. This evidence concerns the gene CDH1 and non-small cell lung carcinoma.